Fisher Funds Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Buy
14,451
+4,000
+38% +$4.09M 0.49% 61
2026
Q1
$9.61M Hold
10,451
0.28% 84
2025
Q4
$11.3M Hold
10,451
0.29% 80
2025
Q3
$7.97M Hold
10,451
0.21% 98
2025
Q2
$8.15M Sell
10,451
-1,161
-10% -$902K 0.19% 91
2025
Q1
$9.59M Hold
11,612
0.23% 85
2024
Q4
$8.94M Buy
+11,612
New +$9.61M 0.22% 81

Other funds holding LLY

Fisher Funds Management's LLY Position: Q2 2026 in Review

Fisher Funds Management increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $4.09M and bringing the position to 14,451 shares worth $17.3M. The position accounts for 0.49% of the portfolio, ranked #61.

Fisher Funds Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fisher Funds Management held 14,451 shares of Eli Lilly worth $17.3M as of Q2 2026.
  • Fisher Funds Management bought 4,000 Eli Lilly shares in Q2 2026, an estimated $4.09M.
  • Eli Lilly made up 0.49% of Fisher Funds Management's portfolio in Q2 2026, its #61 holding.
  • Fisher Funds Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fisher Funds Management's 13F filing for Q2 2026, filed 14 Jul 2026.